INO

NASDAQStock

Inovio Pharmaceuticals, Inc.

$1.67-0.01 (-0.89%)

52-Week Range

$1.31
$2.87

Key Stats

Market Cap

89.2M

P/E Ratio

Dividend Yield

Beta

1.76

Volume

808.0K

Avg Volume

737.0K

Performance

1M

+6.33%

3M

-25.66%

6M

-26.32%

YTD

-0.59%

1Y

-17.24%

3Y

-87.83%

5Y

-98.66%

Price Chart

ETF Exposure

INO is held by 12 ETFs

ETFFund NameWeight
GERMETFMG Treatments, Testing and Advancements ETF0.52%
STSBiShares Factors US Small Blend Style ETF0.04%
IWCiShares Micro-Cap ETF0.02%
SILXETFMG Prime 2x Daily Junior Silver Miners ETF0.00%
VALTETFMG Sit Ultra Short ETF0.00%
VXFVanguard Extended Market ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%

About INO ETF Exposure

Inovio Pharmaceuticals, Inc. (INO) is held by 12 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 89.2M, INO is a widely held institutional stock. The stock currently trades at $1.67. Investors can gain exposure to INO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold INO, sorted by portfolio weight.